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control) of the PCQ it was presented in six focus groups (5–7
women) and in 15 telephone interviews. All interviewees had
previously experienced false positive screening-mammography.
Validation-I: Six hundred women completed the short-term ques-
tionnaire together with the Danish version of the Nottingham
Health Proﬁle (NHP). One-third had had abnormal and two-
thirds had had normal screening-mammography. Validation-II:
One hundred twenty-seventy women who had had false positive
screening mammography up to 6 months ago, and 197 women
with normal mammography completed the long-term question-
naire. Data were analysed using traditional psychometric theo-
ries and Item Response Theories. RESULTS: None of the PCQ
items were found irrelevant. The interviewees, however, found
that not all consequences of false positive screening-mammog-
raphy were covered by the PCQ. Twenty-eight items were gen-
erated (including splitting of double-barrelled item) and it was
decided to divide the questionnaire into 2, 1 measuring short-
term and another long-term consequences. Both questionnaires
were found to be reliable with Cronbach’s Alpha 0.95 and 0.90.
Validation-I: 4 strongly correlated dimensions (24 items in total)
were found to be in order and additive, 4 single items were kept
because of high face validity and ﬁve “bad” items (including one
of the original PCQ items) were deleted. Results on Know Group
Validity and Concurrent Validity (i.e. correlation with the 6 NHP
sections) conﬁrming the a priori hypothesis will be presented at
the conference. Validation-II: No bad items were identiﬁed.
Three strongly correlated dimensions (13 items in total) were
found to be in order and additive. CONCLUSIONS: Two 
reliable and valid instruments, one on short-term and one on
long-term psychosocial consequence of false positive screening-
mammography have been developed and are currently under
adaptation into Norwegian and English.
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OBJECTIVES: To assess the prevalence, health resources usage
(HRU) and cost of Vascular Dementia (VD) in comparison with
that of the Alzheimer Disease (AD) in a population setting in
Spain. There few data available on HRU and cost of VD, and
no information is available in Spain. It is estimated that eco-
nomic impact of VD may be even higher than AD. METHODS:
A cross-sectional & retrospective, observational study with two
phases was designed. In 1st phase, patients with diagnosis of
dementia were selected from a database claim. During 2nd
phase, a clinic evaluation, including administration of Mini-
Mental State Examination, was performed along with data col-
lection on HRU. Direct costs were estimated by sum of HRU
during last 6 months. Also, caregiver burden was determined by
counting the time dedicated to patient care. Descriptive statis-
tics, regression models and bootstrap techniques were used.
RESULTS: A total of 6004 claims were reviewed, of whom 224
out of 258 with dementia fulﬁlled criteria of VD or AD diag-
nostic. Subjects with mixed dementia were excluded from the
analysis. Total prevalence was 4.3% in population above 64
years old and increased with ageing; 64.3% was of AD type, and
28.1% of VD. The total cost of dementia per patient per a 6-
month-period was signiﬁcantly higher for VD than for AD;
10.316€ versus 8.209€, p < 0.05. The proportion of cost attrib-
utable to caregivers was the main component of burden in both
types; 85.5% in AD versus 84.4% in VD. CONCLUSIONS:
Prevalence of dementia increases with ageing, although no socio-
demographics differences could be identiﬁed. Health care costs
are substantial for this disorder, particularly for VD in compar-
ison with AD. Cardiovascular risks prevention in VD should be
associated to a positive impact in health care resources utiliza-
tion for this dementia.
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OBJECTIVES: Assess value of admission stroke severity in pre-
dicting outcomes at discharge for patients with ﬁrst-ever
ischemic stroke in Taiwan. METHODS: Data was prospectively
collected from 360 ﬁrst-ever ischemic stroke patients consecu-
tively admitted to a medical center. Stroke severity was evaluated
with NIH stroke scale (NIHSS) and categorized as mild (0–6),
moderate (7–15), or severe (16–38). Functional independence
status was accessed by modiﬁed Barthel Index (MBI) on a scale
of 0–20. We studied three discharge outcomes: 1) status based
on combined measure of neurological impairment and disability
(excellent, good, improved, poor); 2) neurologic changes (better,
stationary, worse); and 3) functional changes (better, stationary,
worse). For each outcome, a separate polytomous logistic regres-
sion model with least favorable category as the reference group
was constructed, controlling confounding factors. RESULTS:
Patients (58% male) had mean age 64.9 ± 12.7 (range 18–93),
median NIHSS 6 and median MBI 12 on admission. Median
length-of-stay was 7 (range, 1–122) days; in-hospital deaths 8%.
Twenty-two percent (22%) of patients were excellent status
(NIHSS £1 and MBI ≥19), 33% good (NIHSS £6 and MBI ≥12
but not excellent). Twenty-two percent (22%) of patients had
better neurologic change (decrease on NIHSS ≥4), 61% station-
ary (NIHSS changed within ±3); functional change, 14% better
(MBI changed from < 12 to ≥12), 75% stationary (MBI remained
< 12 or ≥12). The odds ratio (OR) for moderate and severe
(versus mild) stroke patients to achieve excellent status were 0.04
(95% CI, 0.02–0.10) and < 0.01, respectively. The OR for mod-
erate stroke patients to have good or improved outcome was
0.19 (0.10–0.36), for severe stroke 0.04 (0.01–0.13). The OR
for moderate and severe (versus mild) stroke patients to have
better neurologic change were 5.18 (1.94–13.85) and 4.12
(1.38–12.30), respectively. CONCLUSIONS: Admission NIHSS
is predictive of clinical outcomes of acute hospitalization after
ﬁrst-ever ischemic stroke.
